Do patients with disabling stroke (mRs >3) benefit from statin treatment?

Most recent guidelines unanimously recommend statin therapy for secondary ischaemic stroke prevention. Ambulatory patients were preferentially included into SPARCL and HPS studies.

13 November 2014 6,273 6 View